| post embryonic development | GO:0009791 | 2 | 0.958 | Worm |
| ncrna metabolic process | GO:0034660 | 108 | 0.383 | |
| ribosome biogenesis | GO:0042254 | 48 | 0.262 | |
| cell projection organization | GO:0030030 | 252 | 0.200 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.183 | |
| single organism cellular localization | GO:1902580 | 332 | 0.175 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.133 | |
| cell morphogenesis | GO:0000902 | 296 | 0.130 | |
| neuron differentiation | GO:0030182 | 138 | 0.115 | |
| rrna metabolic process | GO:0016072 | 40 | 0.094 | |
| generation of neurons | GO:0048699 | 152 | 0.094 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.094 | Fly |
| neuron development | GO:0048666 | 113 | 0.093 | |
| nervous system development | GO:0007399 | 293 | 0.085 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.076 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.074 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.073 | |
| neuron projection development | GO:0031175 | 106 | 0.072 | |
| ncrna processing | GO:0034470 | 83 | 0.071 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.067 | |
| reproductive process | GO:0022414 | 106 | 0.062 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.062 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.062 | Fly |
| embryo development | GO:0009790 | 123 | 0.061 | Worm |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.060 | |
| chemotaxis | GO:0006935 | 157 | 0.059 | |
| protein processing | GO:0016485 | 226 | 0.059 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.057 | |
| segmentation | GO:0035282 | 4 | 0.057 | |
| reproduction | GO:0000003 | 63 | 0.057 | Worm |
| molting cycle | GO:0042303 | 28 | 0.056 | |
| protein localization to organelle | GO:0033365 | 280 | 0.054 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.053 | |
| protein localization to membrane | GO:0072657 | 160 | 0.051 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.049 | |
| mitotic spindle elongation | GO:0000022 | 4 | 0.048 | Fly |
| organophosphate catabolic process | GO:0046434 | 430 | 0.048 | |
| female gamete generation | GO:0007292 | 2 | 0.044 | |
| regulation of oocyte development | GO:0060281 | 1 | 0.041 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.040 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.040 | Fly |
| actin filament based process | GO:0030029 | 224 | 0.040 | |
| oogenesis | GO:0048477 | 2 | 0.036 | |
| reproductive system development | GO:0061458 | 56 | 0.036 | |
| taxis | GO:0042330 | 157 | 0.036 | |
| single organism membrane organization | GO:0044802 | 268 | 0.035 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.034 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.033 | |
| oocyte development | GO:0048599 | 1 | 0.033 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.033 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.032 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.032 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.032 | |
| lipid localization | GO:0010876 | 106 | 0.032 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.029 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.028 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.028 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.028 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.027 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.027 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.027 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.026 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 34 | 0.026 | Worm |
| endocytosis | GO:0006897 | 159 | 0.026 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.026 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.026 | |
| oocyte differentiation | GO:0009994 | 2 | 0.026 | |
| mitochondrial transport | GO:0006839 | 60 | 0.026 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.025 | |
| neuron projection morphogenesis | GO:0048812 | 50 | 0.025 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.025 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.024 | |
| ribonucleoprotein complex biogenesis | GO:0022613 | 116 | 0.023 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.023 | |
| maintenance of location | GO:0051235 | 112 | 0.023 | |
| neurogenesis | GO:0022008 | 169 | 0.023 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.023 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 3 | 0.023 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.023 | |
| rna processing | GO:0006396 | 255 | 0.023 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.023 | |
| vasculature development | GO:0001944 | 181 | 0.021 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.021 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.021 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.021 | |
| myoblast migration | GO:0051451 | 1 | 0.021 | |
| reproductive structure development | GO:0048608 | 55 | 0.020 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.020 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.020 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.019 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.019 | |
| developmental process involved in reproduction | GO:0003006 | 66 | 0.019 | |
| cardiovascular system development | GO:0072358 | 262 | 0.018 | |
| positive regulation of protein complex assembly | GO:0031334 | 86 | 0.018 | |
| growth | GO:0040007 | 202 | 0.018 | |
| nuclear migration | GO:0007097 | 1 | 0.018 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.018 | |
| dna repair | GO:0006281 | 198 | 0.018 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.018 | |
| protein targeting | GO:0006605 | 187 | 0.017 | |
| circulatory system development | GO:0072359 | 262 | 0.017 | |
| sex differentiation | GO:0007548 | 45 | 0.017 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.017 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.017 | |
| regulation of anatomical structure size | GO:0090066 | 101 | 0.017 | |
| tissue regeneration | GO:0042246 | 3 | 0.017 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.016 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.016 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.016 | |
| nuclear division | GO:0000280 | 128 | 0.016 | |
| nucleus localization | GO:0051647 | 1 | 0.016 | |
| regulation of growth | GO:0040008 | 165 | 0.016 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.015 | |
| axon development | GO:0061564 | 34 | 0.015 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.015 | |
| protein maturation | GO:0051604 | 233 | 0.015 | |
| cell development | GO:0048468 | 328 | 0.015 | |
| regulation of vesicle mediated transport | GO:0060627 | 130 | 0.015 | |
| chromosome segregation | GO:0007059 | 114 | 0.015 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.015 | |
| gonad development | GO:0008406 | 34 | 0.015 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.015 | |
| membrane organization | GO:0061024 | 292 | 0.014 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.014 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.014 | |
| chromatin organization | GO:0006325 | 351 | 0.014 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.014 | |
| skeletal muscle tissue growth | GO:0048630 | 2 | 0.014 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.013 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.013 | |
| actomyosin structure organization | GO:0031032 | 59 | 0.013 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.013 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.013 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.013 | |
| glial cell migration | GO:0008347 | 4 | 0.013 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.013 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.013 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.013 | |
| organ morphogenesis | GO:0009887 | 147 | 0.013 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.013 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.013 | |
| regeneration | GO:0031099 | 4 | 0.013 | |
| axonogenesis | GO:0007409 | 31 | 0.012 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.012 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.012 | |
| regulation of protein localization | GO:0032880 | 296 | 0.012 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.012 | |
| regulation of endocytosis | GO:0030100 | 72 | 0.012 | |
| histone modification | GO:0016570 | 251 | 0.012 | |
| positive regulation of growth | GO:0045927 | 58 | 0.012 | |
| maturation of lsu rrna | GO:0000470 | 3 | 0.012 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.012 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.012 | |
| atp metabolic process | GO:0046034 | 176 | 0.012 | |
| blood vessel development | GO:0001568 | 172 | 0.011 | |
| angiogenesis | GO:0001525 | 147 | 0.011 | |
| cell division | GO:0051301 | 168 | 0.011 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.011 | |
| locomotory behavior | GO:0007626 | 1 | 0.011 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.011 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.011 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.011 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.011 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.011 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.011 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.011 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.011 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.010 | |
| zymogen activation | GO:0031638 | 70 | 0.010 | |
| meiotic chromosome segregation | GO:0045132 | 4 | 0.010 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.010 | |
| cell fate determination | GO:0001709 | 3 | 0.010 | |
| innate immune response | GO:0045087 | 178 | 0.010 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.010 | |
| gtp catabolic process | GO:0006184 | 237 | 0.010 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.010 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.010 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.010 | |
